Literature DB >> 25824510

Coronary artery disease. Drug-eluting stents or CABG?

João H Duarte.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25824510     DOI： 10.1038/nrcardio.2015.48

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  2 in total

1.  Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.

Authors:  Jung-Min Ahn; Jae-Hyung Roh; Young-Hak Kim; Duk-Woo Park; Sung-Cheol Yun; Pil Hyung Lee; Mineok Chang; Hyun Woo Park; Seung-Whan Lee; Cheol Whan Lee; Seong-Wook Park; Suk Jung Choo; CheolHyun Chung; JaeWon Lee; Do-Sun Lim; Seung-Woon Rha; Sang-Gon Lee; Hyeon-Cheol Gwon; Hyo-Soo Kim; In-Ho Chae; Yangsoo Jang; Myung-Ho Jeong; Seung-Jea Tahk; Ki Bae Seung; Seung-Jung Park
Journal:  J Am Coll Cardiol       Date:  2015-03-15       Impact factor: 24.094

2.  Trial of everolimus-eluting stents or bypass surgery for coronary disease.

Authors:  Seung-Jung Park; Jung-Min Ahn; Young-Hak Kim; Duk-Woo Park; Sung-Cheol Yun; Jong-Young Lee; Soo-Jin Kang; Seung-Whan Lee; Cheol Whan Lee; Seong-Wook Park; Suk Jung Choo; Cheol Hyun Chung; Jae Won Lee; David J Cohen; Alan C Yeung; Seung Ho Hur; Ki Bae Seung; Tae Hoon Ahn; Hyuck Moon Kwon; Do-Sun Lim; Seung-Woon Rha; Myung-Ho Jeong; Bong-Ki Lee; Damras Tresukosol; Guo Sheng Fu; Tiong Kiam Ong
Journal:  N Engl J Med       Date:  2015-03-16       Impact factor: 91.245
  2 in total
  1 in total

1.  Effects of N-acetyl cysteine and melatonin on early reperfusion injury in patients undergoing coronary artery bypass grafting: A randomized, open-labeled, placebo-controlled trial.

Authors:  Ebrahim Shafiei; Mehrzad Bahtoei; Pema Raj; Afshin Ostovar; Daryoush Iranpour; Samad Akbarzadeh; Hooshang Shahryari; Abdorasoul Anvaripour; Rahim Tahmasebi; Thomas Netticadan; Ali Movahed
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.